First Manhattan’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2,000
| Closed | – | – | 1490 |
|
|
2018
Q1 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 1548 |
|
|
2017
Q4 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 1400 |
|
|
2017
Q3 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 1335 |
|
|
2017
Q2 | $5K | Hold |
2,000
| – | – | ﹤0.01% | 1254 |
|
|
2017
Q1 | $6K | Hold |
2,000
| – | – | ﹤0.01% | 1256 |
|
|
2016
Q4 | $3K | Buy |
+2,000
| New | +$3K | ﹤0.01% | 1309 |
|
|
2016
Q3 | – | Sell |
-2,000
| Closed | -$8K | – | 1545 |
|
|
2016
Q2 | $8K | Hold |
2,000
| – | – | ﹤0.01% | 1270 |
|
|
2016
Q1 | $11K | Hold |
2,000
| – | – | ﹤0.01% | 1157 |
|
|
2015
Q4 | $34K | Sell |
2,000
-100
| -5% | -$1.7K | ﹤0.01% | 1013 |
|
|
2015
Q3 | $44K | Buy |
2,100
+100
| +5% | +$2.1K | ﹤0.01% | 968 |
|
|
2015
Q2 | $99K | Hold |
2,000
| – | – | ﹤0.01% | 828 |
|
|
2015
Q1 | $156K | Hold |
2,000
| – | – | ﹤0.01% | 742 |
|
|
2014
Q4 | $121K | Buy |
2,000
+1,000
| +100% | +$60.5K | ﹤0.01% | 799 |
|
|
2014
Q3 | $42K | Sell |
1,000
-280,006
| -100% | -$11.8M | ﹤0.01% | 998 |
|
|
2014
Q2 | $17.4M | Sell |
281,006
-140,000
| -33% | -$8.65M | 0.11% | 131 |
|
|
2014
Q1 | $27.4M | Sell |
421,006
-75,173
| -15% | -$4.89M | 0.18% | 103 |
|
|
2013
Q4 | $27.9M | Sell |
496,179
-28,620
| -5% | -$1.61M | 0.18% | 100 |
|
|
2013
Q3 | $32.2M | Sell |
524,799
-89,365
| -15% | -$5.48M | 0.22% | 79 |
|
|
2013
Q2 | $46.9M | Buy |
+614,164
| New | +$46.9M | 0.32% | 63 |
|